Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

<p><br></p><p dir="ltr">The global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 coronavirus, has produced an urgent requirement and search for improved treatments while effective vaccines are developed. A strategy for improved drug therapy is...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Maryam S. Al-Motawa (9501818) (author)
مؤلفون آخرون:	Hafsa Abbas (9501821) (author), Patrick Wijten (2029159) (author), Alberto de la Fuente (360936) (author), Mingzhan Xue (3607649) (author), Naila Rabbani (291722) (author), Paul J. Thornalley (291723) (author)
منشور في:	2020
الموضوعات:	Biological sciences Bioinformatics and computational biology Microbiology Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences COVID-19 coronavirus methylglyoxal glyoxalase doxorubicin paclitaxel proteomics bioinformatics
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

مواد مشابهة